Pfizer (PFE) 10K Form and Latest SEC Filings 2026

Pfizer logo
$25.26 -0.67 (-2.57%)
Closing price 03:59 PM Eastern
Extended Trading
$25.24 -0.01 (-0.04%)
As of 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Pfizer SEC Filings & Recent Activity

Pfizer (NYSE:PFE) has submitted 1,418+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Pfizer's financial statements. The most recent filing was a Form 8-K submitted on June 18, 2026.

Form 4
PFIZER INC Reports Ownership Change on Jun. 16, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Pfizer Files Current Report on Jun. 18, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Pfizer Files Quarterly Report on May. 5, 2026

The 10-Q contains Pfizer's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Pfizer SEC Filing History

Browse Pfizer's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
06/18/2026 12:17 PM
Pfizer (78003) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2026 6:07 AM
Pfizer (78003) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2026 3:21 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2026 3:02 PM
Pfizer (78003) Filer
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/16/2026 2:49 PM
Pfizer (78003) Filer
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/10/2026 6:58 PM
DAMICO JENNIFER B. (1805617) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2026 6:42 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2026 3:39 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2026 4:05 PM
Oric Pharmaceuticals, Inc. (1796280) Subject
Pfizer (78003) Filed by
Form SCHEDULE 13G/A
05/12/2026 3:51 PM
Pfizer (78003) Filer
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
05/05/2026 3:42 PM
Pfizer (78003) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/05/2026 6:01 AM
Pfizer (78003) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2026 6:03 AM
Pfizer (78003) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2026 3:20 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 5:37 PM
Echevarria Joseph (1633137) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 5:37 PM
Desmond-Hellmann Susan (1507911) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 5:37 PM
Buckley Mortimer J (2041310) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 5:37 PM
BLAYLOCK RONALD E (1214686) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 5:39 PM
LITTMAN DAN R. (1733004) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 5:39 PM
NORA JOHNSON SUZANNE M (1310264) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 5:40 PM
Gottlieb Scott (1411359) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 5:22 PM
Pfizer (78003) Issuer
Taraporevala Cyrus (1454920) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 5:22 PM
Pfizer (78003) Issuer
SMITH JAMES C (1611777) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 5:22 PM
Pfizer (78003) Issuer
Quincey James (1561264) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 5:23 PM
Hancock Dennis P (2127636) Reporting
Pfizer (78003) Issuer
Form 3/A
04/27/2026 5:23 PM
NARAYEN SHANTANU (1224154) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2026 4:16 PM
Pfizer (78003) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2026 12:16 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2026 3:31 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2026 12:10 PM
Hancock Dennis P (2127636) Reporting
Pfizer (78003) Issuer
Form 3
Initial statement of beneficial ownership of securities  
04/01/2026 4:52 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 7:18 PM
Buckley Mortimer J (2041310) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 7:19 PM
Echevarria Joseph (1633137) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 7:19 PM
NARAYEN SHANTANU (1224154) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 7:20 PM
Pfizer (78003) Issuer
Quincey James (1561264) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 7:21 PM
Pfizer (78003) Issuer
SMITH JAMES C (1611777) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2026 7:22 PM
Pfizer (78003) Issuer
Taraporevala Cyrus (1454920) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 10:22 AM
Pfizer (78003) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/16/2026 4:45 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 8:19 AM
Pfizer (78003) Filer
Form ARS
03/12/2026 8:05 AM
Pfizer (78003) Filer
Form DEF 14A
How to play the Biggest IPO in stock market history! (Ad)

SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insiders and institutional holders have been sitting on positions for years and will exit the moment shares hit the market. Lance Ippolito has identified five stocks directly positioned to benefit from the SpaceX launch and the space investing wave it triggers, without the brutal IPO volatility. These picks carry none of the hype risk and all of the tailwind.tc pixel

Get all five tickers now, completely free
03/12/2026 8:12 AM
Pfizer (78003) Filer
Form DEFA14A
03/05/2026 4:24 PM
de Germay Alexandre (2005574) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 4:25 PM
Pfizer (78003) Issuer
SAHNI PAYAL (1817124) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 4:25 PM
McDermott Michael (1902464) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 4:25 PM
Fonseca Lidia (1454944) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 4:26 PM
Baum Andrew (2029853) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 4:26 PM
MALIK AAMIR (1881510) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 4:26 PM
LANKLER DOUGLAS M (1488270) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 4:26 PM
Denton David M (1428718) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 4:26 PM
BOSHOFF CHRISTOFFEL (1988687) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 4:26 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 4:27 PM
DAMICO JENNIFER B. (1805617) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2026 12:29 PM
DAMICO JENNIFER B. (1805617) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 5:33 PM
BOSHOFF CHRISTOFFEL (1988687) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 5:34 PM
McDermott Michael (1902464) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 5:34 PM
Fonseca Lidia (1454944) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 5:34 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 5:35 PM
DAMICO JENNIFER B. (1805617) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 5:35 PM
LANKLER DOUGLAS M (1488270) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 5:35 PM
Pfizer (78003) Issuer
SAHNI PAYAL (1817124) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 11:44 AM
Pfizer (78003) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2026 2:40 PM
DAMICO JENNIFER B. (1805617) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2026 2:41 PM
BOSHOFF CHRISTOFFEL (1988687) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2026 3:22 PM
Pfizer (78003) Filer
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/03/2026 6:01 AM
Pfizer (78003) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2026 4:55 PM
BOSHOFF CHRISTOFFEL (1988687) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 1:32 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2026 3:59 PM
Echevarria Joseph (1633137) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2026 3:59 PM
Buckley Mortimer J (2041310) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2025 1:36 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2025 6:01 AM
Pfizer (78003) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2025 4:32 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2025 3:16 PM
Pfizer (78003) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2025 3:14 PM
Pfizer (78003) Filer
Form 424B5
11/18/2025 7:15 AM
Pfizer (78003) Filer
Form 424B3
11/17/2025 8:02 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2025 4:01 PM
Pfizer (78003) Filer
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
11/04/2025 6:00 AM
Pfizer (78003) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2025 6:03 AM
Pfizer (78003) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2025 4:19 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2025 4:19 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2025 6:52 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 5:09 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025 10:31 AM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2025 2:03 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 4:08 PM
Pfizer (78003) Filer
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
08/05/2025 6:16 AM
Pfizer (78003) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2025 6:08 AM
Pfizer (78003) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2025 9:23 AM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2025 5:20 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
07/02/2025 12:07 PM
BOURLA ALBERT (1595703) Reporting
Pfizer (78003) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Pfizer SEC Filings - Frequently Asked Questions

Pfizer (PFE) has submitted 1,418+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Pfizer's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Pfizer's financial statements page.

The most recent filing was a Form 8-K submitted on June 18, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:PFE) was last updated on 6/18/2026 by MarketBeat.com Staff.
From Our Partners